LIVZON PHARMA (01513) announced that at the 2025 annual general meeting, the board of directors re-elected Mr. Zhu Baoguo, Mr. Lin Nanqi, and Mr. Qiu Qingfeng as non-executive directors of the 12th board. The board re-elected Mr. Tang Yanggang and elected Mr. Liu Daping as executive directors of the 12th board. Furthermore, the board re-elected Mr. Luo Huiyuan, Ms. Cui Lijie, and Ms. Wang Zhiyao, and elected Ms. Kang Li as independent non-executive directors of the 12th board. Following a qualification review by the board's nomination committee, the staff congress democratically elected Ms. Ran Yongmei as an employee representative director of the company's 12th board. In addition, the board agreed to appoint Mr. Liu Daping as the company's president. The board also agreed to appoint Mr. Du Jun, Mr. Xu Xiao, Mr. Chen Zhihua, and Ms. Huang Yuxuan as vice presidents. It agreed to appoint Mr. Wang Sheng as the company's chief financial officer, Ms. Liu Ning as the board secretary and company secretary, and Ms. Xia Yu as the representative for securities affairs at the Shenzhen Stock Exchange.